Novant Health Hemby Children's Hospital — Charlotte, North Carolina

Novant Health Hemby Children's Hospital is a clinical research site located in Charlotte, North Carolina, United States 28204.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Novant Health Hemby Children's Hospital has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Lymphoblastic Leukemia, Sickle Cell Disease, Osteosarcoma in Children.

Sponsors: Tanja Andrea Gruber, St. Jude Children's Research Hospital, Wake Forest University Health Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novant Health Hemby Children's Hospital?

Novant Health Hemby Children's Hospital has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novant Health Hemby Children's Hospital conducted?

Novant Health Hemby Children's Hospital has 3 clinical trials on record, with 3 currently active. Their work covers Lymphoblastic Leukemia, Sickle Cell Disease, Osteosarcoma in Children.

Is Novant Health Hemby Children's Hospital accredited by Crixeo Clinical Trials?

Novant Health Hemby Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novant Health Hemby Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.